Alendronic and gastrointestinal haemorrhage Patient Reports February 11, 2012

Alendronic Side Effects Report #5965589-X
Alendronic side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Nov 12, 2008. Female patient, 86 years of age, was diagnosed with osteoporosis prophylaxis, acute myocardial infarction and was treated with Alendronic. After drug was administered, patient experienced the following side effects: acute myocardial infarction, erosive oesophagitis, gastric ulcer, gastrointestinal haemorrhage. Alendronic dosage: 70 MG ONCE WEEKLY ORAL. During the same period patient was treated with CLOPIDOGREL, DALTEPARIN, ADCAL, ACETYLSALICYLIC ACID SRT, BISOPROLOL FUMARATE, CODEINE PHOSPHATE AND ACETAMINOPHEN, DIGOXIN, FUROSEMIDE. Patient was hospitalized. Patient recovered.

Alendronic Side Effects Report #5978079-5
Alendronic side effect was reported by a Health Professional from UNITED KINGDOM on Nov 13, 2008. Female patient, 86 years of age, was diagnosed with osteoporosis prophylaxis, acute myocardial infarction and was treated with Alendronic. After drug was administered, patient experienced the following side effects: gastrointestinal haemorrhage, haemoglobin decreased. Alendronic dosage: 70 MG; WEEKLY; ORAL. During the same period patient was treated with CLOPIDOGREL, DALTEPARIN, ADCAL, ASPIRIN, BISOPROLOL FUMARATE, ACETAMINOPHEN W, DIGOXIN, FUROSEMIDE. Patient was hospitalized. Patient recovered.

Alendronic Side Effects Report #5801461-3
Alendronic side effect was reported by a Health Professional from UNITED KINGDOM on June 30, 2008. Male patient, 86 years of age, weighting 169.8 lb, was diagnosed with osteoporosis  and was treated with Alendronic. After drug was administered, patient experienced the following side effects: gastrointestinal haemorrhage, haematemesis, melaena, multi-organ failure. Alendronic dosage: unknown. Patient was hospitalized. Patient died on 11/09/2006.

Alendronic Side Effects Report #6089140-1
Alendronic side effect was reported by a Health Professional from UNITED KINGDOM on Feb 13, 2009. Female patient, 84 years of age, was diagnosed with osteoporosis  and was treated with Alendronic. After drug was administered, patient experienced the following side effects: gastrointestinal haemorrhage, melaena. Alendronic dosage: unknown. Patient was hospitalized. Patient recovered.


Alendronic Side Effects Report #6093888-2
Alendronic side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Feb 12, 2009. Female patient, 84 years of age, was diagnosed with osteoporosis  and was treated with Alendronic. After drug was administered, patient experienced the following side effects: gastrointestinal haemorrhage, melaena. Alendronic dosage: 70 MG ONCE A WEEK ORAL. During the same period patient was treated with ADCAL, AMITRIPTYLINE HYDROCHLORIDE, FLOXACILLIN, FLUDROCORTISONE ACETATE, HYDROCORTISONE, IBUPROFEN, OMEPRAZOLE, PARACETAMOL. Patient was hospitalized. Patient recovered.

Alendronic Side Effects Report #6103872-8
Alendronic side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Feb 12, 2009. Female patient, 84 years of age, was diagnosed with osteoporosis  and was treated with Alendronic. After drug was administered, patient experienced the following side effects: gastrointestinal haemorrhage, melaena. Alendronic dosage: 70 MG; ORAL; WEEKLY. During the same period patient was treated with ADCAL, AMITRIPTYLINE HYDROCHLORIDE, FLOXACILLIN, FLUDROCORTISOINE, HYDROCORTISONE, IBUPROFEN, OMEPRAZOLE, PARACETAMOL. Patient was hospitalized. Patient recovered.

Alendronic Side Effects Report #5873858-7
Alendronic side effect was reported by a Health Professional from UNITED KINGDOM on Aug 14, 2008. Female patient, 86 years of age, was treated with Alendronic. After drug was administered, patient experienced the following side effects: cardiac arrest , gastric ulcer, gastrointestinal haemorrhage, hypercalcaemia. Alendronic dosage: unknown. During the same period patient was treated with ADCAL, AMLODIPINE, ATENOLOL. Patient was hospitalized and became disabled. Patient died.